Subtotal gastrectomy (i.e., partial removal of the stomach), a surgical treatment for early-stage distal gastric cancer, is usually accompanied by highly selective vagotomy and Billroth II reconstruction, leading to dramatic changes in the gastric environment. Based on accumulating evidence of a strong link between human gut microbiota and host health, a 2-year follow-up study was conducted to characterize the effects of subtotal gastrectomy. Gastric microbiota and predicted gene functions inferred from 16S rRNA gene sequencing were analyzed before and after surgery. The results demonstrated that gastric microbiota is significantly more diverse after surgery. Ralstonia and Helicobacter were the top two genera of discriminant abundance in the cancerous stomach before surgery, while Streptococcus and Prevotella were the two most abundant genera after tumor excision. Furthermore, N-nitrosation genes were prevalent before surgery, whereas bile salt hydrolase, NO and N2O reductase were prevalent afterward. To our knowledge, this is the first report to document changes in gastric microbiota before and after surgical treatment of stomach cancer.
Advances in sequencing technologies and analytical methods have enabled characterization of the human gut microbiota. As part of the human gut, the stomach is inhabited by a wide variety of bacteria, despite the long-held notion of it being a hostile environment for microbial colonization1,2. In healthy individuals, several genera other than Helicobacter, including Streptococcus, Prevotella, Veillonella, Rothia and Neisseria, are abundant in the stomach, based on cloning3,4 and pyrosequencing5,6. Regarding effects of diseases, the gastric microbiota shifts towards decreasing diversity with progression of gastritis, intestinal metaplasia and gastric cancer7. However, the gastric microbiota of elderly stomach cancer patients does not significantly differ from that of dyspeptic controls8. Although chronic infection with Helicobacter pylori causes serious gastric complications, there are no significant associations between microbial phylotypes and H. pylori status of the stomach3. In that regard, H. pylori status only explains 28% of the variance in gastric microbiota, whereas 44% is explained by host factors9. Understanding of human gastric microbiota is in its infancy and is complicated by changes over time in persons with complicated gastric syndromes (which require long-term follow-up and invasive sampling).
Subtotal gastrectomy (i.e., partial removal of the stomach) is a surgical treatment for distal gastric cancer, a multifactorial disease causing numerous cancer-related deaths around the world10. Patients receiving subtotal gastrectomy for gastric cancer are often subjected to other surgical procedures, which alter the gastric environment. For example, highly selective vagotomy affects gastric secretion of gastric acid11; cholecystectomy elevates gastric pH value12; Billroth II reconstruction reduces pancreatic polypeptide secretion13. Following subtotal gastrectomy, there are several common side effects, including marginal ulcers, bile reflux and stump cancer. Bile reflux after subtotal gastrectomy has been associated with the presence of Streptococcus and Veillonella in gastric aspirates14 and Escherichia, Klebsiella and Clostridium in the intestine15. Although gastric microbiota is altered after subtotal gastrectomy14, changes in diversity have not been well characterized. Despite characterization of gastric microbiota by culture-independent approaches, changes following subtotal gastrectomy in patients with gastric cancer are not completely understood. Therefore, there are many knowledge gaps, leading to a number of questions. For example, are different anatomic sites inhabited by different microbes? What is the compositional variation in gastric microbiota after subtotal gastrectomy? What is the biodiversity pattern before and after subtotal gastrectomy? Do metabolic functions embedded in gastric microbiota correspond to changes caused by subtotal gastrectomy? In this study, we aimed to address these questions by deep sequencing of microbial 16S ribosomal RNA (rRNA) genes in gastric tissues.
Gastric microbiota in gastric cancer patients (at various anatomic sites and before and after subtotal gastrectomy) was characterized by 16S rRNA gene sequencing. Within the 2-year timeframe of this follow-up study, 24 gastric biopsies were collected from 6 patients subjected to subtotal gastrectomy. Variations in gastric microbiota and predicted gene functions before and after tumor excision (subtotal gastrectomy) were determined.
Statistical summaries of sequencing results
To characterize stomach bacterial microbiota and potential variations associated with subtotal gastrectomy, we collected tumor (abbreviated as T in figures) and non-tumor (N) tissues before surgery, as well as gastric stump (S) and high body (B) tissues after surgery, from 6 gastric cancer patients. A total of 4.6 million pair-end reads were generated, of which 3.2 million reads passed quality filtering and were non-chimeric. To determine bacterial community diversity and composition, reads were aligned to the Greengenes database and non-bacterial sequences removed. On average, 85% of reads in a sample were retained. In total, 2.7 million reads (on average, 113 ± 42 thousand reads per sample) were used for subsequent analyses.
Based on 16S rRNA gene sequencing data, bacterial richness (number of operational taxonomic units (OTUs), richness value and Chao 1 index) increased after surgery (P < 0.01, one-tailed Student’s t-test; Table 1). Similarly, there was greater diversity of bacterial communities after surgery (Shannon index) than before surgery (P < 0.01, one-tailed Student’s t-test; Table 1). However, within patients, there were no differences (P > 0.05, two-tailed paired t-test of Shannon indices) between tumor and non-tumor tissues (before surgery) or between gastric stump and high body tissues (after surgery). Before-surgery communities were characterized by rarefaction curves approaching an asymptote, whereas after-surgery communities were characterized by curves with steeper slopes (Figure S1), indicating the potential for greater diversity to be discovered with more sequencing efforts. Good’s coverage estimates sampling completeness by calculating the probability that a randomly selected read from a sample has been sequenced. At 97% sequence similarity level, Good’s coverage values for all sampled bacterial communities ranged from 0.964 to 0.996 (except T594S, with 0.893 Good’s coverage) when estimated using all reads (Table S1).
Bacterial community structure
Bacterial abundance (i.e., read count) was normalized by corresponding copy number of 16S rRNA genes (prior to community compositional analysis) to reduce potential bias of abundance estimation due to copy number variation16. Before surgery, stomach microbiota in tumor and non-tumor tissues was dominated by the phyla Proteobacteria (80% in N and 67% in T) and Actinobacteria (15% in N and 24% in T), followed by Firmicutes and Bacteroidetes (<4% in both N and T; Fig. 1A). However, after surgery, Firmicutes and Bacteroidetes dramatically increased in both gastric stump and high body tissues (32 and 20% respectively, on average), while Proteobacteria and Actinobacteria decreased (Fig. 1A).
At the class level, there was obvious personal variation in stomach microbiota. For example, in 3 before-surgery samples Epsilonproteobacteria was dominant (>95%), whereas 5 samples harbored Actinobacteria (at least 25%; Fig. 1B). After surgery, Bacilli (of Firmicutes) and Bacteroidia (of Bacteroidetes) significantly increased in the stomach of most patients, representing (on average) 25 and 19% of the microbiota, respectively.
Principal component analysis (PCA) with surgery status as instrumental variable revealed significant differences in bacterial genera abundance before and after surgery (P = 0.0001, Monte-Carlo simulation; Fig. 1C). Furthermore, from the results of linear discriminant analysis (LDA) effect size (LEfSe) analysis17, there were a total of 63 known genera with differential abundance before and after surgery. Among 19 genera known to be more abundant before surgery, Ralstonia and Helicobacter were the two with the largest LDA effect size (Fig. 1D), whereas Streptococcus and Prevotella represented the top two genera (of 43) after surgery.
Group differences (i.e., before and after surgery) in bacterial community structure were also observed using the Bray-Curtis measure of beta diversity18. The within-group distance was significantly lower than the between-group distance when samples were divided into before- and after-surgery groups (P < 0.001; Fig. 2A). However, comparisons between tumor and non-tumor tissues before surgery (Fig. 2B) and between gastric stump and high body tissues after surgery (Fig. 2C) showed insignificant or only marginally significant differences in distances. Interestingly, community dissimilarity within patients was lower than that between patients (regardless of surgery status), although only after-surgery communities demonstrated a significant difference (Fig. 2D).
Bacterial gene functions
Based on the community structure derived from 16S rRNA gene sequencing data, predicted gene functions of each sample were inferred from referenced bacterial genomes19. Enrichment analysis was performed (two-group comparison20) to identify gene functions of differential abundances that were significantly enriched (Benjamini-Hochberg adjusted P < 0.05) in bacterial microbiota before and after surgery. In agreement with the dramatically changed community composition, there were 1879 and 2394 Clusters of Orthologous Groups (COGs) enriched in samples before (Table S2) and after surgery (Table S3), respectively. Given that there were so many genes of differential abundance and based on the understanding of metabolic diversity of gut microbiota21,22, functional genes related to gastric disease and carcinogenesis were prioritized for further investigation.
Metabolic enzymes involved in denitrification (e.g., nitrate and nitrite reductases) were more abundant in the gastric microbiota before surgery (Fig. 3A). Furthermore, genes related to nitrosation (conversion of organic compounds to nitroso derivatives) were also more abundant before surgery, including the gene families of phenol degradation (Fig. 3A; COG4313) and cytochrome (COG3474 and COG3258). From pathway-centric comparisons, biosynthesis of various vitamins, including biotin (vitamin H), riboflavin (vitamin B12), pyridoxal phosphate (vitamin B6), cobalamin (vitamin B12), thiamine (vitamin B1) and menaquinone (vitamin K), was more prevalent in the gastric microbiota before surgery than after surgery (Table S4). Conversely, after-surgery gastric microbiota encoded more bile salt hydrolase (Fig. 3B; COG3049 and K01442) and genes related to reduction of nitric oxide (NO) and nitrous oxide (N2O). There were 36 COG Pathways enriched in the gastric microbiota after surgery (Table S5).
This is the first follow-up study in which deep sequencing is applied to investigate the stomach microbiota in gastric cancer patients before and after subtotal gastrectomy. This study is also the first to predict gene functions associated with variations in gastric microbiota. There was an obvious shift in community composition of the gastric microbiota after surgery. Decreases in Proteobacteria and Actinobacteria and increases in Firmicutes and Bacteroidetes defined the after-surgery microbiota shift (at phylum level). Ralstonia and Helicobacter were the top two genera of discriminant abundance in the stomach of patients with gastric cancer, while Streptococcus and Prevotella were the top two genera after surgery. In contrast, there was relatively low divergence of gastric microbiota among various sites in the stomach. Corresponding to the community shift, the gastric microbiota also exhibited differential predicted gene functions. For example, denitrification and nitrosation genes were prevalent in patient stomachs before surgery, whereas bile salt hydrolase and NO and N2O reductases were prevalent after surgery.
After gastrectomy, the stomach was dominated by only four phyla (Proteobacteria, Firmicutes, Bacteroidetes and Actinobacteria), which are in abundance in the gastric microbiota of healthy individuals3,5. The relative abundance of these phyla covaries with H. pylori status9. Composition of the gastric microbiota gradually changes along with progression of gastric diseases (from gastritis to intestinal metaplasia and ultimately gastric cancer7,23). This study extended observations corresponding to surgical removal of gastric cancer tissue, resulting in increases in Firmicutes and Bacteroidetes and decreases in Actinobacteria and Proteobacteria.
In the present study, gastric cancer tissue and neighboring normal tissue demonstrated similar microbiota. After subtotal gastrectomy, the within-patient microbiota revealed even greater similarity between gastric stump and high body tissues, similar to the findings of a previous report in which there was little difference in gastric microbiota between antrum and body biopsy specimens4. Based on cultures of biopsy specimens, 62% of gastric microbiota exist in both the antrum and body of the stomach24, which is as expected as these two sites are distinct niches for microbial colonization, given their differential ability to secrete gastric acid25. Based on the present results and those of previous studies, we inferred that the gastric environment as a whole is more critical than the individual anatomical sites in determining microbial composition.
Gastric acidity is a barrier to microbial overgrowth26,27. However, the secretion of gastric acid is reduced after vagotomy11 (i.e., cutting branches of the vagus nerve), resulting in a mildly acidic stomach that allows for more bacterial colonization26 (mostly ingested). Similarly, acid-reducing drugs reportedly increase bacterial colonization in stomach28. This phenomenon correlated with our results that the richness and diversity (Shannon index) of gastric microbiota increased in after-surgery samples. Another potential side effect of vagotomy is cobalamin deficiency, due to decreased gastric intrinsic factor29. Consistent with this prediction, our pathway-centric comparison identified decreased abundance of genes for biosynthesis of cobalamin (and other vitamins) after surgery. Therefore, growth of bacteria lacking cobalamin synthesis genes might be the microbial response following vagotomy that contributes to cobalamin deficiency, although it has been proposed that gastrointestinal bacteria in humans are competitors for cobalamin rather than contributors30.
In addition to vitamin biosynthesis, other predicted gene functions of differential abundances were analyzed before and after surgery. For example, nitrate and nitrite reductase, phenol degradation gene and cytochrome were differentially abundant before surgery, all of which are related to bacteria-mediated N-nitrosation22. It is known that N-nitroso compounds are causative factors in carcinogenesis. Therefore, the enrichment of genes functionally associated with N-nitrosation before surgery was in agreement with the findings of the cancerous stomach in this study. Since cytochrome commonly presents in respiratory chains and nitrate reductase is used by many Proteobacteria for anaerobic respiration, the differential abundance of these genes was likely a reflection of the high level of Proteobacteria before surgery. As for nitrite reductase, COG1251 (nirB) and COG2146 (nirD) are functionally associated with nitrate assimilation in various bacteria31, suggesting that these two genes are not involved in gastric NO production. To confirm the phenomenon, further experiments are required.
After surgery, the gastric microbiota demonstrated increases in bile salt hydrolase (COG3049 and K01442), NO reductase (COG3256 and COG3901) and N2O reductase (COG4263). After Billroth II reconstruction and cholecystectomy (i.e., gallbladder removal), bile salts continuously pass through the stomach (bile reflux) due to anatomical change. This phenomenon speculatively changes the gastric environment in patients after surgery, making the stomach a potential niche for microbes capable of degrading bile salts. This plausibly explains the enrichment of bile salt hydrolase in gastric microbiota after subtotal gastrectomy. Furthermore, NO can be produced enzymatically by activated leukocytes and bacteria32 and its bactericidal effect has been suggested to protect the stomach from pathogenic colonization33. However, bacterial NO reductase participates in the defense against NO toxicity34, implying that the gastric microbiota has a higher capability of NO detoxification after surgery than before surgery. Abundant N2O reductase after surgery corresponds to the reported increase in N2O concentration after partial gastrectomy35, although the microbial effect of N2O in stomach is not fully understood.
In conclusion, subtotal gastrectomy alters gastric microbiota in terms of diversity, community composition and predicted gene functions. These changes in the microbial community of the stomach are closely associated with the altered gastric environment after subtotal gastrectomy.
Study subjects and gastric tissue specimen collection
Gastric tissue specimens were collected from early-stage gastric cancer patients before and after curative subtotal gastrectomy at Taichung Veterans General Hospital. Patients with previous malignancies or who had received chemotherapy, radiation therapy or prior gastric surgery were excluded. In addition, patients who had received proton pump inhibitors, H2 receptor antagonists, antibiotics, or probiotics within 1 month of tissue collection were excluded.
Gastric cancerous tissues and neighboring non-tumor tissues were collected before surgery. All patients underwent subtotal gastrectomy, which included excision of 40–50% stomach, vagotomy, cholecystectomy and Billroth II reconstruction. Bile flow was through the stomach after surgery due to the method of Billroth II reconstruction. Approximately 2 years after subtotal gastrectomy, gastric tissue specimens were collected from the gastric stump (1 cm away from the anastomosis site) and high body of the lesser curvature of the stomach. Comprehensive oral explanations were given and signed informed consent was obtained from all study subjects. The experiments were carried out in accordance with the protocols approved by the Institute Review Board of Taichung Veterans General Hospital.
Bacterial genomic DNA extraction
Bacterial genomic DNA was extracted with the Qiagen DNA Mini Kit (Qiagene, MD, USA). Briefly, tissue samples (~20 mg) yielded 15–20 μg genomic DNA for direct use in polymerase chain reaction (PCR) assays and 16S rRNA gene sequencing. Each tissue sample was homogenized by adding lysozyme (100 mg/mL, Sigma-Aldrich, St. Louis, MO, USA) to lysis buffer to promote lysis of Gram-positive bacteria, thereby enhancing total DNA yields. Amount and quality of isolated genomic DNA were determined with NanoDrop ND-1000 (Thermo Scientific, Wilmington, DE, USA). Genomic DNA was stored at –80 °C prior to 16S rRNA sequencing.
16S rRNA sequencing and analysis
The hypervariable region V1–V3 of bacterial 16S rRNA genes was amplified by PCR using bar-coded universal primers 27F (F, forward primer; 5′-AGAGTTTGATCMTGGCTCAG-3′) and 534R (R, reverse primer; 5′-GTATTACCGCGGCKGCTG-3′)36,37. Library construction and sequencing of amplicon DNA samples were conducted with Genomics BioScience (Taipei, Taiwan). A pair-end library (insert size of 490 bp for each sample) was constructed with TruSeq Nano DNA Library Prep kit (Illumina, San Diego, CA, USA) and high-throughput sequencing was performed on an Illumina MiSeq 2000 sequencer with MiSeq Reagent Kit v3 (Illumina).
On a per-sample basis, pair-end reads were merged using USEARCH (v7.0.1090)38, with minimum overlap of read pair set at eight base pairs (bp). Merged reads were quality-filtered with Mothur (v1.34.3)39 to remove reads shorter than 450 bp or longer than 550 bp, as well as reads with minimum average quality score <27. In addition, reads containing an ambiguous base or homopolymer exceeding 8 bp were excluded. Chimera detection was performed using USEARCH (reference mode and 3% minimum divergence).
Quality-filtered and non-chimeric reads were analyzed (UPARSE40 pipeline) to generate OTUs per sample (at 97% identity level). The OTU representative sequences were searched against the Greengenes 13_5 database using USEARCH global alignment to identify the corresponding taxonomy of the best hit. Any OTU without a hit or with only a weak hit, i.e. the function “(% sequence identity + % alignment coverage)/2” was <93, was excluded from further analysis. The abundance of each taxon was counted and corrected with PICRUSt19, in which the pipeline divided the read count of each taxon by the corresponding 16S rRNA gene copy number. Diversity indices (e.g., Shannon, Simpson, Chao 1 and Good’s coverage) were estimated with Mothur.
Statistical analysis of bacterial community
All statistical analyses were performed using R software (http://www.r-project.org/), unless otherwise specified. Gene copy number-corrected abundance of genera was total-sum scaled per sample. A pseudocount of 0.0001 was added to the relative abundance (in percentage) before logarithmic transformation41. PCA was performed on log-transformed data using the R package ade442 to analyze genera abundance before and after surgery. Between-group inertia percentages were tested (Monte-Carlo test with 10000 permutations) to determine the P-values of PCA results. To identify organismal features differentiating communities of stomach bacteria before and after surgery, LEfSe17 was applied with α = 0.05 (Kruskal-Wallis and Wilcoxon tests) and effect size threshold of 2 on linear discriminant analysis (LDA) through the web site, http://huttenhower.sph.harvard.edu/galaxy. Community structure similarities within and between groups were assessed using the Bray-Curtis distance18 via the R package vegan43, based on relative abundance of bacterial genera.
Prediction and analysis of gene functions of bacterial microbiota
Metabolic profiles of bacterial communities were predicted with PICRUSt, which forecasts abundance of genes of metabolic function based on the 16S copy number-corrected OTU composition. Functional genes were categorized (by PICRUSt) into COGs and KEGG Orthology (KO) gene families. To identify gene functions that differentiated bacterial communities before and after surgery, COG gene abundance was subjected to enrichment analysis of two-group comparison, using the R package ShotgunFunctionalizeR20. This analysis normalized gene abundances using a generalized linear model with Poisson canonical logarithmic link function and determined differential significance (P-value) via a binomial method with a Benjamini-Hochberg false discovery rate correction to adjust q-values for multiple testing. In addition to gene-centric analysis, ShotgunFunctionalizeR was used to perform pathway-centric analysis. The sets of functionally related COG families were grouped into COG Pathways and COG Categories based on JGI IMG/M44. To identify pathways of differential abundance before and after surgery, the two-group comparison of pathways was performed by ShotgunFunctionalizeR using Poisson model to determine differential significance (P-value) via a binomial method with a Benjamini-Hochberg false discovery rate correction to adjust q-values for multiple testing.
Accession codes: Illumina pair-end sequencing reads of 24 samples were deposited in the NCBI Sequence Read Archive (accession numberSRP057951).
How to cite this article: Tseng, C.-H. et al. Gastric microbiota and predicted gene functions are altered after subtotal gastrectomy in patients with gastric cancer. Sci. Rep. 6, 20701; doi: 10.1038/srep20701 (2016).
Wu, W. M., Yang, Y. S. & Peng, L. H. Microbiota in the stomach: new insights. J Dig Dis 15, 54–61 (2014).
Yang, I., Nell, S. & Suerbaum, S. Survival in hostile territory: the microbiota of the stomach. FEMS Microbiol Rev 37, 736–761 (2013).
Bik, E. M. et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA 103, 732–737 (2006).
Li, X. X. et al. Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use. PLoS One 4, e7985 (2009).
Andersson, A. F. et al. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 3, e2836 (2008).
Delgado, S., Cabrera-Rubio, R., Mira, A., Suarez, A. & Mayo, B. Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods. Microb Ecol 65, 763–772 (2013).
Aviles-Jimenez, F., Vazquez-Jimenez, F., Medrano-Guzman, R., Mantilla, A. & Torres, J. Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep 4, 4202 (2014).
Dicksved, J. et al. Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol 58, 509–516 (2009).
Maldonado-Contreras, A. et al. Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J 5, 574–579 (2011).
Polk, D. B. & Peek, R. M., Jr. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 10, 403–414 (2010).
Jepson, K. & Johnston, D. Effect of vagotomy on human gastric acid secretion stimulated by gastrin pentapeptide and by histalog. Gastroenterology 55, 665–669 (1968).
Brown, T. H., Walton, G., Cheadle, W. G. & Larson, G. M. The alkaline shift in gastric pH after cholecystectomy. Am J Surg 157, 58–65 (1989).
Rieu, P. N., Jansen, J. B., Hopman, W. P., Joosten, H. J. & Lamers, C. B. Effect of partial gastrectomy with Billroth II or Roux-en-Y anastomosis on postprandial and cholecystokinin-stimulated gallbladder contraction and secretion of cholecystokinin and pancreatic polypeptide. Dig Dis Sci 35, 1066–1072 (1990).
Poxon, V. A., Morris, D. L., Youngs, D. J., Albutt, E. C. & Keighley, M. R. Exposure to bile acids and bacteria over 24 hours following partial gastrectomy, vagotomy and pyloroplasty. World J Surg 10, 981–989 (1986).
Domellof, L., Reddy, B. S. & Weisburger, J. H. Microflora and deconjugation of bile acids in alkaline reflux after partial gastrectomy. Am J Surg 140, 291–295 (1980).
Kembel, S. W., Wu, M., Eisen, J. A. & Green, J. L. Incorporating 16S gene copy number information improves estimates of microbial diversity and abundance. PLoS Comput Biol 8, e1002743 (2012).
Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol 12, R60 (2011).
Bray, J. R. & Curtis, J. T. An ordination of the upland forest communities of southern Wisconsin. Ecol Monogr 27, 326–349 (1957).
Langille, M. G. et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 31, 814–821 (2013).
Kristiansson, E., Hugenholtz, P. & Dalevi, D. ShotgunFunctionalizeR: an R-package for functional comparison of metagenomes. Bioinformatics 25, 2737–2738 (2009).
Blaut, M. & Clavel, T. Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr 137, 751S–755S (2007).
Hillman, B. Role of gut bacteria in human toxicology and pharmacology. 1st edn, (CRC Press, 2004).
Eun, C. S. et al. Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal metaplasia and gastric cancer using pyrosequencing methods. Helicobacter 19, 407–416 (2014).
Khosravi, Y. et al. Culturable bacterial microbiota of the stomach of Helicobacter pylori positive and negative gastric disease patients. Scientific World J 2014, 610421 (2014).
Sachs, G., Weeks, D. L., Melchers, K. & Scott, D. R. The gastric biology of Helicobacter pylori. Annu Rev Physiol 65, 349–369 (2003).
Giannell, Ra, Zamcheck, N. & Broitman, S. A. Gastric-acid barrier to ingested microorganisms in man: studies in-vivo and in-vitro. Gut 13, 251–256 (1972).
Martinsen, T. C., Bergh, K. & Waldum, H. L. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol 96, 94–102 (2005).
Mowat, C. et al. Omeprazole, Helicobacter pylori status and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology 119, 339–347 (2000).
Streeter, A. M., Duraiappah, B., Boyle, R., O’Neill, B. J. & Pheils, M. T. Malabsorption of vitamin B12 after vagotomy. Am J Surg 128, 340–343 (1974).
Degnan, P. H., Taga, M. E. & Goodman, A. L. Vitamin B12 as a modulator of gut microbial ecology. Cell Metab 20, 769–778 (2014).
Lin, J. T. & Stewart, V. Nitrate assimilation by bacteria. Adv Microb Physiol 39, 1–30 (1998).
Patel, B. A. & Crane, B. R. When it comes to antibiotics, bacteria show some NO-how. J Mol Cell Biol 2, 234–236 (2010).
Benjamin, N. et al. Stomach NO synthesis. Nature 368, 502 (1994).
Bowman, L. A., McLean, S., Poole, R. K. & Fukuto, J. M. The diversity of microbial responses to nitric oxide and agents of nitrosative stress close cousins but not identical twins. Adv Microb Physiol 59, 135–219 (2011).
Mitsui, T. & Kondo, T. Increased breath nitrous oxide after ingesting nitrate in patients with atrophic gastritis and partial gastrectomy. Clin Chim Acta 345, 129–133 (2004).
Kumar, P. S., Brooker, M. R., Dowd, S. E. & Camerlengo, T. Target region selection is a critical determinant of community fingerprints generated by 16S pyrosequencing. PLoS One 6, e20956 (2011).
Mao, D. P., Zhou, Q., Chen, C. Y. & Quan, Z. X. Coverage evaluation of universal bacterial primers using the metagenomic datasets. BMC Microbiol 12, 66 (2012).
Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460–2461 (2010).
Schloss, P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75, 7537–7541 (2009).
Edgar, R. C. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 10, 996–998 (2013).
Costea, P. I., Zeller, G., Sunagawa, S. & Bork, P. A fair comparison. Nat Methods 11, 359 (2014).
Dray, S. & Dufour, A. B. The ade4 package: Implementing the duality diagram for ecologists. J Stat Softw 22, 1–20 (2007).
Dixon, P. V. E. G. A. N., a package of R functions for community ecology. J Veg Sci 14, 927–930 (2003).
Markowitz, V. M. et al. IMG/M: a data management and analysis system for metagenomes. Nucleic Acids Res 36, D534–538 (2008).
This work was supported in part by the Ministry of Science and Technology (NSC-103-2314-B-030-004-MY2) and the Biodiversity Research Center of Academia Sinica, Taiwan.
The authors declare no competing financial interests.
About this article
Cite this article
Tseng, CH., Lin, JT., Ho, H. et al. Gastric microbiota and predicted gene functions are altered after subtotal gastrectomy in patients with gastric cancer. Sci Rep 6, 20701 (2016). https://doi.org/10.1038/srep20701
BMC Cancer (2022)
Comparison of the gastric microbiome in Billroth I and Roux-en-Y reconstructions after distal gastrectomy
Scientific Reports (2022)
Long-term persistence of gastric dysbiosis after eradication of Helicobacter pylori in patients who underwent endoscopic submucosal dissection for early gastric cancer
Gastric Cancer (2021)
Comment on: “Long‑term persistence of gastric dysbiosis after eradication of Helicobacter pylori in patients who underwent endoscopic submucosal dissection for early gastric cancer. Gastric Cancer, 2020 Nov 17” by Watanabe et al.
Gastric Cancer (2021)
Severe preeclampsia is associated with a higher relative abundance of Prevotella bivia in the vaginal microbiota
Scientific Reports (2020)